Yusuf Hamied

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Yusuf Hamied
Born (1936-07-25) 25 July 1936 (age 80)
Wilno, Wilno Voivodeship, Poland (now Vilnius, Lithuania)
Citizenship Indian
Institutions Cipla
Alma mater Christ's College, Cambridge
Thesis Chemistry of the aphins (1961)
Notable awards Padma Bhushan

Yusuf Khwaja Hamied (born 25 July 1936) is a billionaire Indian scientist and businessman, the chairman of Cipla, a generic pharmaceuticals company founded by his father Khwaja Abdul Hamied in 1935.[1]

Early life[edit]

Hamied was raised in Bombay. His Indian Muslim father and Russophone Jewish mother met in pre-war Berlin, where they were graduate students. Hamied was educated at the Cathedral and John Connon School in Bombay.[citation needed] He holds a PhD in chemistry from Christ's College, Cambridge. He uses his chemistry notebooks from Cambridge when he develops new syntheses of drugs.[2]

Career[edit]

Hamied is best known outside India for defying large Western pharmaceutical companies in order to provide generic AIDS drugs and treatments for other ailments primarily affecting people in poor countries.[3] Hamied has led efforts to eradicate AIDS in the developing world and to give patients life-saving medicines regardless of their ability to pay,[4] and has been characterized as a modern-day Robin Hood figure[5][6][7][8] as a result.

Hamied stated, "I don't want to make money off these diseases which cause the whole fabric of society to crumble". [9]

In September 2011, in a piece about how he was trying to radically lower costs of biotech drugs for cancer, diabetes and other noncommunicable diseases, The New York Times wrote of Hamied:

Dr. Yusuf K. Hamied, chairman of the Indian drug giant Cipla Ltd., electrified the global health community a decade ago when he said he could produce cocktails of AIDS medicines for $1 per day — a fraction of the price charged by branded pharmaceutical companies. That price has since fallen to 20 cents per day, and more than six million people in the developing world now receive treatment, up from little more than 2,000 in 2001.[10]

Hamied has also been influential in pioneering development of multi-drug combination pills (also known as fixed-dose combinations, or FDCs), notably for HIV/AIDS, tuberculosis (TB), asthma and other ailments chiefly affecting developing countries, as well as development of pediatric formulations of drugs, especially those benefiting children in poor settings.[11] These innovations have greatly expanded access to medicine and increased drug safety by ensuring proper dosages are taken. He is also highly regarded for his role in expanding the production of bulk drugs and "active pharmaceutical ingredients" (APIs, the active chemical components in medicines) in India.[12]

In 2009 the Yusuf Hamied Centre was opened at Christ's College, Cambridge.[13][14]

Hamied has been the subject of in-depth profiles in The New York Times, Time magazine, The Guardian, Le Monde, The Economist, the Financial Times, The Times (London), Corriere della Sera, Der Spiegel, Wired and numerous other leading publications, as well as on television outlets such as ABC News, the BBC, CNN and CBS' 60 Minutes.[15]

In February 2013, Hamied announced his retirement plans from Cipla after remaining managing director of the company for 52 years. [16] At the time, he was listed as the 28th richest Indian by Forbes magazine.[17]

Awards and recognition[edit]

He was awarded the Padma Bhushan, India's third highest civilian honour by Government of India in 2005.[18]

Hamied was awarded the 'CNN-IBN Indian of the Year' in the category of business by CNN-IBN in 2012 for "for taking on multinational pharma companies and making some of the essential drugs more affordable to the masses in the developing countries. In late 2013, he was also named one of the India's "25 Greatest Global Living Legends" by news broadcaster NDTV.[19][20] He was also recently interviewed for the Creating Emerging Markets project at the Harvard Business School, discussing at length his strategies to provide AIDS treatments and other drugs to help treat poor people in the developing world.[21][22]

Media[edit]

Hamied's role in the battle for mass antiretroviral treatment in Africa is portrayed in the documentary Fire in the Blood (2013 film).[23] In its review of the film, India Today noted that "the story of Yusuf Hamied will make every Indian proud as he was the only man who decided to walk against the tide and sell drugs to save lives without focusing on profits."[24]

Personal life[edit]

Yusuf Hamied is married to Farida.[25] His niece, Samina Vaziralli, daughter of his younger brother, M. K. Hamied, Cipla's non-executive vice-chairman, is part of the next generation of leadership at Cipla.[26]

As of January 2016, he has a net worth of US$1.45 billion.[17]

References[edit]

  1. ^ Sarah Boseley (2003-02-18). "Yusuf Hamied, generic drugs boss | World news". London: The Guardian. Retrieved 2010-09-01. 
  2. ^ Donald G. McNeil Jr (2000-12-01). "Selling Cheap 'Generic' Drugs, India's Copycats Irk Industry". The New York Times. Retrieved 2016-01-26. 
  3. ^ "Indian drugs boss hails Aids deal". 2003-10-29. Retrieved 2016-09-07. }
  4. ^ "Interview of the week: Yusuf Hamied. - United Press International | HighBeam Research - FREE trial". Highbeam.com. 2001-02-22. Retrieved 2010-09-01. 
  5. ^ "Yusuf Hamied, un Robin Hood contro l' Aids «Così sconfiggerò l' Aids senza le multinazionali»". Archiviostorico.corriere.it. Retrieved 2016-01-26. 
  6. ^ Bobin, Frédéric (2010-07-06). "India fears generic drugs for poor are endangered by proposed EU trade deal". The Guardian. London. 
  7. ^ "TransIP - Reserved domain". Legacy.laika.nl. Retrieved 2016-01-26. 
  8. ^ "English Summaries - SPIEGEL ONLINE". Spiegel.de. 2001-04-02. Retrieved 2016-01-26. 
  9. ^ Hans Lofgren, The Politics of the Pharmaceutical Industry and Access to Medicine, 2012.
  10. ^ Harris, Gardiner (2011-09-18). "China and India Making Inroads in Biotech Drugs". The New York Times. 
  11. ^ Hans Lofgren, The Politics of the Pharmaceutical Industry and Access to Medicine, 2012, p. 58-59
  12. ^ Hans Lofgren, The Politics of the Pharmaceutical Industry and Access to Medicine, 2012, p. 63
  13. ^ "Christ's officially opens Yusuf Hamied Centre". University of Cambridge News. 2009-04-20. Retrieved 2009-04-20. 
  14. ^ "The Hindu News Update Service". Chennai, India: Hindu.com. 2009-04-22. Retrieved 2010-09-01. 
  15. ^ "Yusuf Hamied, generic drugs boss". 2003-02-18. Retrieved 2016-09-07. 
  16. ^ "Grand old man of Cipla Yusuf K Hamied hangs his boots". Economic Times. Feb 7, 2013. Retrieved 2013-11-08. 
  17. ^ a b "Yusuf Hamied". Forbes. Retrieved 26 January 2016. 
  18. ^ "Padma Awards Directory (1954–2009)" (PDF). Ministry of Home Affairs. Archived from the original (PDF) on May 10, 2013. 
  19. ^ "Dr. Yusuf Hamied message on being CNN-IBN's Indian of The Year 2012 in the business category". CNN-IBN. Dec 17, 2012. Retrieved 2013-11-08. 
  20. ^ [1] Archived January 9, 2014, at the Wayback Machine.
  21. ^ "Dr. Yusuf Hamied - Creating Emerging Markets - Business History - Harvard Business School". Hbs.edu. Retrieved 2016-01-26. 
  22. ^ https://www.youtube.com/watch?v=Sra-N-gQp-Y&feature=youtu.be, "Doing Good by Doing Business," Creating Emerging Markets
  23. ^ "The Contributors". Fire in the Blood. 2013-01-20. Retrieved 2016-01-26. 
  24. ^ "Movie Review: Fire in the Blood". 2013-10-10. Retrieved 2016-09-07. 
  25. ^ "Undiplomatic departure from London". Telegraphindia.com. Retrieved 2016-01-26. 
  26. ^ "Cipla chief Yusuf K Hamied grooms niece & nephew Samina Vaziralli & Kamil Hamied as genext leaders". Articles.economictimes.indiatimes.com. Retrieved 2016-01-26.